ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
GX Acquisition Corporation

GX Acquisition Corporation (GXGX)

10,20
0,00
(0,00%)
Fermé 05 Novembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
10,20
Prix Achat
10,24
Prix Vente
10,34
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
10,20
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
193 782 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-10,07
Bénéfice par action (BPA)
-1,01
Chiffre d'affairess
22,77M
Bénéfice net
-196,3M

À propos de GX Acquisition Corporation

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-

GXGX Dernières nouvelles

GX Acquisition Corp. Announces Shareholder Approval of Extension Proposal

GX Acquisition Corp. Announces Shareholder Approval of Extension Proposal PR Newswire NEW YORK, May 14, 2021 NEW YORK, May 14, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a...

GX Acquisition Corp. Announces Additional Contributions to Trust Account

GX Acquisition Corp. Announces Additional Contributions to Trust Account PR Newswire NEW YORK, May 10, 2021 NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a...

Celularity Enters into Multi-Year Strategic Partnership with Palantir Technologies

Celularity to leverage Palantir’s next generation software and computational capabilities with their deep cellular data set to accelerate research and development activities Partnership includes...

GX Acquisition Corp. Provides Information Regarding Extension of Deadline to Complete Celularity Business Combination

GX Acquisition Corp. Provides Information Regarding Extension of Deadline to Complete Celularity Business Combination PR Newswire NEW YORK, April 16, 2021 NEW YORK, April 16, 2021 /PRNewswire/...

Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Thera...

Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy - Celularity has entered into a definitive merger agreement with...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SPPLSIMPPLE Ltd
US$ 1,18
(268,75%)
401,57M
NUWENewellis Inc
US$ 2,80
(105,88%)
99,64M
ADNAdvent Technologies Holdings Inc
US$ 3,34
(75,79%)
64,31M
STAFStaffing 360 Solutions Inc
US$ 2,8301
(66,48%)
52,44M
OMICSingular Genomics Systems Inc
US$ 22,28
(65,53%)
320,13k
TOIIWOncology Institute Inc
US$ 0,0101
(-47,67%)
58,23k
SSPEW Scripps Company
US$ 2,2701
(-35,51%)
4,25M
GCTKGlucoTrack Inc
US$ 1,15
(-33,91%)
82,44k
ILLRTriller Group Inc
US$ 2,86
(-33,18%)
2,32M
FGFFundamental Global Inc
US$ 15,2501
(-31,46%)
209,33k
SPPLSIMPPLE Ltd
US$ 1,18
(268,75%)
401,58M
ELABElevai Labs Inc
US$ 0,0202
(-30,10%)
288,54M
NVDANVIDIA Corporation
US$ 136,05
(0,48%)
187,36M
SQQQProShares UltraPro Short QQQ
US$ 7,52
(1,08%)
167,17M
DJTTrump Media and Technology Group Corporation
US$ 34,34
(12,37%)
120,77M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock